Content thumbnail Quest Diagnostics Corporate Responsibility Report
AI Content Chat (Beta) logo

2021 CORPORATE RESPONSIBILITY REPORT I 56 EMPLOYEE ENGAGEMENT & RECOGNITION Accolades awarded to our colleagues In 2021, our Quest colleagues received multiple honors recognizing their critical work. This included distinguished awards to forensic toxicologist Dr Barry Sample and pathologist Dr Kari Hooper. Barry Sample, PhD, Employer Solutions Senior Director of Science and Technology, received the National Drug and Alcohol Screening Association (NDASA) Lifetime Achievement Award. The award was presented in St. Louis during the NDASA Annual Conference in May 2021, with Quest as a major sponsor. The Lifetime Achievement Award celebrates Barry's dedication to promoting public safety and drug-free workplaces and communities through education and excellence in drug screening services. Officially retired as of January 2022, Barry will continue as Senior Science Consultant for Employer Solutions. A board-certified forensic toxicologist, Barry worked for Quest Diagnostics for more than 30 years, starting in 1991 as laboratory director. Under his direction, the Atlanta laboratory, which was accredited by the International Olympic Committee, provided the doping control services for the 1996 Centennial Olympic Games. In 2000, Barry transitioned to leading science and technology initiatives where he was responsible for new testing, informatics, and technology development, and the Quest Diagnostics Drug Testing Index. Barry is a regional commissioner and an inspector for the College of American Pathologists Forensic Drug Testing laboratory accreditation program, and serves as a member of the Department of Health and Human Services Drug Testing Advisory Board. He is a lecturer and has co-authored numerous presentations and publications addressing drug analysis, athletic drug testing, and toxicology. Kari Hooper, MD, Director of Hematopathology at AmeriPath, was named Woman of the Year by the Leukemia and Lymphoma Society (LLS) of Oklahoma. LLS is a global leader, funding life-saving blood cancer research across the world, and providing free information and supportive resources. Kari was nominated by her colleague, Oncology Genomic Account Executive Christina Lohmeyer. With Christina as team captain, Kari and her teammates together raised more than $62,000 for LLS. “I looked into their mission, and I was all in,” Kari explained. "Not only do they give money toward advancing research, but they know it's important to support patients at a micro, local level. When they called my name, I couldn't help but feel proud for my whole team." "On a personal level,” she added, “I spend much of my time at work diagnosing blood cancers, but I don't often meet the patients affected by these diagnoses. I saw this fundraising effort as a tangible way I could contribute to their path back to health.” Barry Sample, PhD Kari Hooper, MD TABLE OF CONTENTS 2021 OVERVIEW COVID-19 RESPONSE PROMOTING A HEALTHIER WORLD CREATING AN INSPIRING WORKPLACE BUILDING VALUE REFERENCES

Quest Diagnostics Corporate Responsibility Report - Page 56 Quest Diagnostics Corporate Responsibility Report Page 55 Page 57